|
|
|
|
|
Legal status
Patent revoked (after opposition at EPO)
| (51) | INT.CL. | C12N 5/00 | (2006.01) |
| (11) | Number of the document | 2522717 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12160789.9 |
| Date of filing the European patent application | 2007-01-03 | |
| (97) | Date of publication of the European application | 2012-11-14 |
| (45) | Date of publication and mention of the grant of the patent | 2014-04-02 |
| (46) | Date of publication of the claims translation | 2014-07-25 |
| (30) | Number | Date | Country code |
| 756419 P | 2006-01-04 | US |
| (72) |
Grillberger, Leopold, AT
Reiter, Manfred, AT
Mundt, Wolfgang, AT
Mitterer, Artur, AT
|
| (73) |
Takeda Pharmaceutical Company Limited,
1-1, Doshomachi 4-chome, Chuo-ku, Osaka-shi, Osaka,
JP
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Ląstelių kultūros terpė be oligopeptidų |
| Oligopeptide-free cell culture media |
| Payment date | Validity (years) | Amount | |
| 2021-12-15 | 16 | 347.00 EUR |
| Patent revoked (after opposition at EPO) | ||
| Invalidation date | 2022-07-12 |